Actuarial probability of failure-free survival following treatment with CSA alone or CSA + ATG. Failure-free survival is defined as survival with response. Death, nonresponse by 6 months, disease progression requiring a second course of immunosuppressive therapy or a stem-cell transplant, and relapse were considered treatment failures.